MvPI Compliance Alert 2026: New Adverse Event Reporting Rules
IPC's January 2026 directive tightens adverse event reporting for medical device MAHs via ADRMS. Here's what license holders must do…
Read MoreRegulatory updates, compliance insights, and industry analysis from the ACPL team.
IPC's January 2026 directive tightens adverse event reporting for medical device MAHs via ADRMS. Here's what license holders must do…
Read MorePHARMACOVIGILANCE • REGULATORY CONSULTING • INDIA Pharmacovigilance Consulting Services in India Professional pharmacovigilance and drug-safety consulting support for pharmaceutical companies,…
Read MoreLooking for a CDSCO consultant in Delhi? ACPL provides drug registration, import licensing, medical device, IVD and CDSCO compliance support…
Read MoreLooking for a CDSCO consultant in India? ACPL offers CDSCO registration, drug import licensing, medical device, IVD and regulatory compliance…
Read More
Entering the Indian Pharmaceutical Market: A Practical Guide for European Pharma Companies India’s pharmaceutical market is massive, but it’s not…
Read MoreMeat, poultry and seafood businesses face tighter FSSAI scrutiny in 2026 — new turnover thresholds, a sausage-standard deadline, and zero…
Read More
CPCB just made life easier for anyone managing EPR accounts with their new “Lost Credentials” feature. If you’re stuck because…
Read More
CDSCO clarification 10 August 2026, globally unapproved new drugs India, Form CT-18, NDCT Rules 2019, Phase III Global Clinical Trial…
Read More
BIS Certification, BIS Registration, BIS Application Rejection, BIS Certification Consultant, BIS Registration Consultant, BIS CRS Registration, ISI Mark Certification, BIS…
Read MoreCDSCO has floated a tender to build a next-gen Digital Drugs Regulatory System while SUGAM adds new modules. Here's what…
Read More